PrECOG, LLC, today announced the publication of final results from the pivotal phase 3 PATINA study in the New England ...

Adding Ibrance to maintenance therapy extends progression-free survival by 15.2 months in HR-positive, HER2-positive ...

Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...

Johns Hopkins University cancer researcher Mikala Egeblad has received the 2025 Ernst W. Bertner Memorial Award in ...

Experts discuss the small but promising study.

Researchers have discovered how pancreatic cancer reprograms its surroundings to spread quickly and stealthily. By using a ...

A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer ...

Researchers say cancer's ability to evade treatment and recur is partly due to tumor cells switching between states to ...

People with compromised liver function may be able to reduce their risk of liver cancer or slow its progression with a simple ...

The study of cancer genomics has revealed that both inherited (germline) and acquired (somatic) genetic variations significantly influence cancer ...